Aortic root abscess: reconstruction of the left ventricular outflow tract and allograft aortic valve and root replacement

  • Charles A. Yankah
  • M. Pasic
  • Henryk Siniawski
  • Y. Weng
  • Roland Hetzer


Active infective aortic endocarditis complicated by abscess formation remains a life-threatening disease and continues to challenge cardiovascular surgeons. Sir William Osler first described endocarditis in the Gulstonian lectures at the Royal College of Physicians in 1885 as a malignant disease that is in all its forms a mycotic process. An aortic root abscess can be diagnosed very early at its onset by transthoracic and transesophageal echocardiography with a sensitivity and specificity of 98 and 100%, respectively [1, 2, 3]. If after diagnosis, during antibiotic therapy, associated complications occur, such as burrowing abscess formation and fistulous communication between the aorta and the right atrium or the right ventricle, interventricular septum, aneurysm of the sinus Valsalva, pseudoaneurysmal formation of an abscess cavity and mitral incompetence, then urgent surgical intervention is mandatory, otherwise fatal cardiovascular complications are imminent [1, 2, 3, 4, 5].


Aortic Valve Infective Endocarditis Aortic Root Aortic Valve Replacement Prosthetic Valve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists, Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. Circulation 114:e84–e231CrossRefPubMedGoogle Scholar
  2. 2.
    Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A, Pavie A, Soler-Soler J, Thiene G, von Graevenitz A, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Fernández Burgos E, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Lekakis J, Vahanian A, Delahaye F, Parkhomenko A, Filipatos G, Aldershvile J, Vardas P, Task Force Members on Infective Endocarditis of the European Society of Cardiology, ESC Committee for Practice Guidelines (CPG), Document Reviewers (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25:267–276Google Scholar
  3. 3.
    Siniawski H, Lehmkuhl H, Weng Y, Pasic M, Yankah C, Hoffman M, Behnke I, Hetzer R (2003) Stentless aortic valves as an alternative to homografts for valve replacement in active infective endocarditis complicated by ring abscess. Ann Thorac Surg 75:803–808CrossRefPubMedGoogle Scholar
  4. 4.
    Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, Fowler VG Jr, Woods CW, Engemann JJ, Corey GR, Harding T, Cabell CH (2007) Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis 44:364–372CrossRefPubMedGoogle Scholar
  5. 5.
    Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ (2003) Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA 290:3207–3214CrossRefPubMedGoogle Scholar
  6. 6.
    Wallace AG, Young WG, Osterhout S (1965) Treatment of acute bacterial endocarditis by valve excision and replacement. Circulation 31:450–453PubMedGoogle Scholar
  7. 7.
    Robicsek F, Payne RB, Daugherty HK, Sanger PW (1967) Bacterial endocarditis of the mitral valve treated by excision and replacement. Ann Surg 166:854–857CrossRefPubMedGoogle Scholar
  8. 8.
    Acar C, Iung B, Cormier B, Grare P, Berrebi A, D’Attellis N, Acar J, Carpentier A (1994) Double mitral homograft for recurrent bacterial endocarditis of the mitral and tricuspid valves. J Heart Valve Dis 3:470–472PubMedGoogle Scholar
  9. 9.
    Pomar JL, Mestres CA (1993) Tricusüid valve replacement using a mitral homograft. Surgical technique and initial results. J Heart Valve Dis 2:125–128PubMedGoogle Scholar
  10. 10.
    Oswalt JD (1993) Pulmonary autograft for aortic endocarditis. J Heart Valve Dis 2:380–384PubMedGoogle Scholar
  11. 11.
    Oswalt JD (1997) Pulmonary autograft for aortic valve endocarditis. In: Yankah CA, Hetzer R, Yacoub MH (eds) Cardiac allografts. Steinkopff/Springer, Darmstadt New York, p 179Google Scholar
  12. 12.
    Somerville J, Ross D (1982) Homograft replacement of aortic root with reimplantation of coronary arteries. Results after one to five years. Br Heart J 47:473–482CrossRefPubMedGoogle Scholar
  13. 13.
    Lau JK, Robles A, Cherian A, Ross D (1984) Surgical treatment of prosthetic endocarditis. Aortic root replacement using a homograft. J Thorac Cardiovasc Surg 87: 712–716PubMedGoogle Scholar
  14. 14.
    Perelman MJ, Sugimoto J, Arcilla RA, Karp RB (1989) Aortic root replacement for complicated bacterial endocarditis in an infant. J Pediatr Surg 24:1121–1123CrossRefPubMedGoogle Scholar
  15. 15.
    Donaldson RM, Ross DM (1984) Homograft aortic root replacement for complicated prosthetic valve endocarditis. Circulation 70(Suppl I):I-178–I-181Google Scholar
  16. 16.
    Ross D (1964) Homotransplantation of the aortic valve in the subcoronary position. J Thoracic Cardiovasc Surg 47:713–719Google Scholar
  17. 17.
    Barratt-Boyes BG (1964) Homograft aortic valve replacement in aortic incompetence and stenosis. Thorax 19:131–150CrossRefPubMedGoogle Scholar
  18. 18.
    Ross D (1991) Technique of aortic valve replacement with a homograft: orthotopic replacement. Ann Thorac Surg 52:154–156PubMedGoogle Scholar
  19. 19.
    Jones EL (1989) Freehand homograft aortic valve replacement. The learning curve: a technical analysis of the first 31 patients. Ann Thorac Surg 48:26–32PubMedCrossRefGoogle Scholar
  20. 20.
    Doty JR, Salazar JD, Iiddicoat JR, Flores JH, Doty DB (1998) Aortic valve replacement with cryopreserved aortic allograft: ten-year experience. J Thorac Cardiovasc Surg 115:371–380CrossRefPubMedGoogle Scholar
  21. 21.
    Barratt-Boyes BG, Christie GW (1994) What is the best bioprosthetic operation for the small aortic root?: allograft, autograft, porcine, pericardial? Stented or unstented? J Card Surg 9(2 Suppl):158–164CrossRefPubMedGoogle Scholar
  22. 22.
    Yankah CA, Klose H, Musci M, Siniawski H, Hetzer R (2001) Geometric mismatch between homograft (allograft) and native aortic root: a 14-year clinical experience. Eur J Cardiothorac Surg 20:835–841CrossRefPubMedGoogle Scholar
  23. 23.
    d’Udekem Y, David TE, Feindel CM, Armstrong S, Sun Z (1997) Long-term results of surgery for active infective endocarditis. Eur J Cardiothorac Surg 11:46–52CrossRefPubMedGoogle Scholar
  24. 24.
    Petrou M, Wong K, Albertucci M, Brecker SJ, Yacoub MH (1994) Evaluation of unstented aortic homografts for the treatment of prosthetic aortic valve endocarditis. Circulation 90(Part 2):II-198–II-204Google Scholar
  25. 25.
    Haydock D, Barratt-Boyes B, Macedo T, Kirklin JW, Blackstone E (1992) Aortic valve replacement for active infectious endocarditis in 108 patients. J Thorac Cardiovasc Surg 103:130–139PubMedGoogle Scholar
  26. 26.
    Schmidtke C, Dahmen G, Sievers HH (2007) Subcoronary Ross procedure in patients with active endocarditis. Ann Thorac Surg 83(1)36–39CrossRefPubMedGoogle Scholar
  27. 27.
    Miller DC (1990) Predictors of outcome in patients with prosthetic valve endocarditis and potential advantages of homograft aortic root replacement for prosthetic ascending aortic valve-graft infections. J Card Surg 5:53–62CrossRefPubMedGoogle Scholar
  28. 28.
    David TE (1997) Surgical management of aortic root abscess. J Card Surg 12:262–269PubMedGoogle Scholar
  29. 29.
    Niwaya K, Knott-Craig CJ, Santangelo K, Lane MM, Chandrasekaran K, Elkins RC (1999) Advantage of autograft and homograft valve replacement for complex aortic valve endocarditis. Ann Thorac Surg 67(6):1603–1608CrossRefPubMedGoogle Scholar
  30. 30.
    Tingleff JF, Pettersson G (1995) Expanding indications for the Ross operation. J Heart Valve Dis 4(4):352–363PubMedGoogle Scholar
  31. 31.
    Yankah CA, Hetzer R (1987) Valve selection and choice in surgery of endocarditis. J Cardiac Surg 2(Suppl):209–220Google Scholar
  32. 32.
    Yankah CA, Klose H, Petzina R, Musci M, Siniawski H, Hetzer R (2002) Surgical management of acute aortic root endocarditis with viable homograft: 13-year experience. Eur J Cardiothorac Surg 21:260–267CrossRefPubMedGoogle Scholar
  33. 33.
    Yankah CA, Pasic M, Klose H, Siniawski H, Weng Y, Hetzer R (2005) Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study. Eur J Cardiothorac Surg 28:69–75CrossRefPubMedGoogle Scholar
  34. 34.
    Anderson RH (2000) Anatomy: clinical anatomy of the aortic root. Heart 84:670–673CrossRefPubMedGoogle Scholar
  35. 35.
    Vogt PR, von Segesser LK, Niederhauser U, Genoni M, Kunzli A, Schneider J, Turina MI (1997) Emergency surgery for acute infective aortic valve endocarditis: performance of cryopreserved homografts and mode of failure. Eur J Cardiothorac Surg 11:53–61CrossRefPubMedGoogle Scholar
  36. 36.
    McGiffin DC, Galbraith AJ, O’Brien MF, McLachlan GJ, Naftel DC, Adams P, Reddy S, Early L (1997) An analysis of valve re-replacement after aortic valve replacement with biologic devices. J Thorac Cardiovasc Surg 113(2):311–318CrossRefPubMedGoogle Scholar
  37. 37.
    Smedira NG, Blackstone EH, Roselli EE, Laffey CC, Cosgrove DM (2006) Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration of allograft and pericardial prostheses. J Thorac Cardiovasc Surg 131:558–564CrossRefPubMedGoogle Scholar
  38. 38.
    Barratt-Boyes BG, Christie GW, Raudkivi PJ (1992) The stentless bioprosthesis: surgical challenges and implications for long-term durability. Eur J Cardiothorac Surg 6(Suppl 1):S39–S43CrossRefPubMedGoogle Scholar
  39. 39.
    Albert A, Florath I, Rosendahl U, Hassanein W, Hodenberg EV, Bauer S, Ennker I, Ennker J (2007) Effect of surgeon on transprosthetic gradients after aortic valve replacement with Freestyle stentless bioprosthesis and its consequences: A follow-up study in 587 patients. J Cardiothorac Surg 2:40CrossRefPubMedGoogle Scholar
  40. 40.
    Ali A, Halstead JC, Cafferty F, Sharples L, Rose F, Coulden R, Lee E, Dunning J, Argano V, Tsui S (2006) Are stentless valves superior to modern stented valves? A prospective randomized trial. Circulation 114(1 Suppl):I535–I540PubMedGoogle Scholar
  41. 41.
    Ennker J, Albert A, Rosendahl U, Ennker IC, Dalladaku F, Florath I (2008) Ten-year experience with stentless aortic valves: Full-root versusu subcoronary implantation. Ann Thorac Surg 85:445–453CrossRefPubMedGoogle Scholar
  42. 42.
    Bach DS, Cartier PC, Kon ND, Johnson KG, Deeb GM, Doty DB (2002) Impact of implant technique following freestyle stentless aortic valve replacement. Ann Thorac Surg 74:1107–1114CrossRefPubMedGoogle Scholar
  43. 43.
    Bach DS, Kon ND, Dumesnil JG, Sintek CF, Doty DB (2005) Ten-year outcome after aortic valve replacement with the Freestyle stentless bioprosthesis. Ann Thorac Surg 80:480–487CrossRefPubMedGoogle Scholar
  44. 44.
    Emery RW, Erickson CA, Arom KV, Northrup WF 3rd, Kersten TE, Von Rueden TJ, Lillehei TJ, Nicoloff DM (2003) Replacement of the aortic valve in patients under 50 years of age: long-term follow-up of the St. Jude Medical prosthesis. Ann Thorac Surg 75:1815–1819CrossRefPubMedGoogle Scholar
  45. 45.
    Cox DR (1972) Regression models and life tables. JR Stat Soc (B) 34:187–220Google Scholar
  46. 46.
    Nicks R, Cartmill T, Bernstein L (1970) Hypoplasia of the aortic root. The problem of aortic valve replacement. Thorax 25:339–346CrossRefPubMedGoogle Scholar
  47. 47.
    Bentall H, De Bono A (1968) A technique for complete replacement of the ascending aorta. Thorax 23:338–339CrossRefPubMedGoogle Scholar
  48. 48.
    Yankah CA, Sievers HH, Buersch JH, Radtcke W, Lange PE, Heintzen PH, Bernhard A (1984) Orthotopic transplantation of aortic valve allograft. Early hemodynamic results. Thorac Cardiovasc Surg 32:92–95CrossRefPubMedGoogle Scholar
  49. 49.
    Yankah CA, Wottge H-U, Mueller-Hermelink HK, Feller AC, et al (1987) Transplantation of aortic and pulmonary allografts, enhanced viability of endothelial cells by cryopreservation, importance of histocompatibility. J Cardiac Surg 2 (Suppl): 209–220Google Scholar
  50. 50.
    Yacoub M, Rasmi NRH, Sundt TM, Lund O, Boyland E, Radley-Smith R, Khagani A, Mitchell A (1995) Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg 110:186–194CrossRefPubMedGoogle Scholar
  51. 51.
    Fux CA, Wilson S, Stoodley P (2004) Detachment characteristics and oxacillin resistance of Staphylococcus aureus biofilm emboli in an invitro catheter infection model. J Bacteriol 186:4486–4491CrossRefPubMedGoogle Scholar
  52. 52.
    Lemos JAC, Brown Jr TA, Burne RA (2004) Effects of Re1A on key virulence properties of planktonic and biofilm populations of Streptococcus mutans. Infect Immun 72:1431–1440CrossRefPubMedGoogle Scholar
  53. 53.
    Jefferson KK (2004) What drives bacteria to produce a biofilm? Fed Eur Microbiol Soc Microbiol Lett 236:163–173Google Scholar
  54. 54.
    Carpentier A (1983) Cardiac valve surgery—The “French correction”. J Thorac Cardiovasc Surg 86:323–337PubMedGoogle Scholar
  55. 55.
    Elkins RC (1996) Pulmonary autografts in patients with aortic annulus dysplasia. Ann Thorac Surg 61:1141–1145CrossRefPubMedGoogle Scholar
  56. 56.
    Knosalla C, Weng Y, Yankah CA, Siniawski H, Hofmeister J, Hammerschmidt R, Loebe M, Hetzer R (2000) Homograft versus prosthetic valve for surgical treatment of aortic valve endocarditis with periannular abscess Eur Heart J 21:490–497CrossRefPubMedGoogle Scholar
  57. 57.
    David TE, Armstrong S, Sun Z (1998) The Hancock II bioprosthesis at 12 years. Ann Thorac Surg 66(6 Suppl):S95–S98CrossRefPubMedGoogle Scholar
  58. 58.
    Neville PH, Aupart MR, Diemont FF, Sirinelli AL, Lemoine EM, Marchand MA (1998) Carpentier-Edwards pericardial bioprosthesis in aortic or mitral position: a 12-year experience. Ann Thorac Surg 66(6 Suppl):S143–S147CrossRefPubMedGoogle Scholar
  59. 59.
    Yankah CA, Pasic M, Musci M, Stein J, Detschades C, Siniawski H, Hetzer R (2008) Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. J Thorac Cardiovasc Surg 136:688–696CrossRefPubMedGoogle Scholar
  60. 60.
    O’Brien MF, Harrocks S, Stafford EG, Gardner MA, Pohlner PG, Tesar PJ, Stephen F (2001) The homograft aortic valve: a 29-year, 99.3% follow up of 1,022 valve replacements. J Heart Valve Dis 10:334–345PubMedGoogle Scholar
  61. 61.
    Lund O, Chandrasekaran V, Grocott-Mason R, Elwidaa H, Mazhar R, Khaghani A, Mitchell A, Ilslev C, Yacoub MH (1999) Primary aortic valve replacement with allografts over twenty-five years: valve-related and procedure-related determinants of outcome. J Thorac Cardiovasc Surg 117:77–91CrossRefPubMedGoogle Scholar
  62. 62.
    Myken PSU, Bech-Hansen O (2009) A 20-year experience of 1712 patients with the Biocor porcine bioprosthesis. J Thorac Cardiovasc Surg 137:76–81CrossRefPubMedGoogle Scholar
  63. 63.
    Jamieson WR, Burr LH, Miyagishima RT, Germann E, MacNab JS, Stanford E, Chan F, Janusz MT, Ling H (2005) Carpentier-Edwards supra-annular aortic porcine bioprosthesis: clinical performance over 20 years. J Thorac Cardiovasc Surg 130:994–1000CrossRefPubMedGoogle Scholar
  64. 64.
    Borger MA, Ivanov J, Armstrong S, Christie-Hrybinsky D, Feindel CM, David TE (2006) Twenty-year results of the Hancock II bioprosthesis. J Heart Valve Dis 15(1):49–56PubMedGoogle Scholar
  65. 65.
    Khan SS, Trento A, De Robertis M, Kass RM, Sandhu M, Czer LS, Blanche C, Raissi S, Fontana GP, Cheng W, Chaux A, Matloff JM (2001) Twenty-year comparison of tissue and mechanical valve replacement. J Thorac Cardiovasc Surg 122: 257–269CrossRefPubMedGoogle Scholar
  66. 66.
    Eichinger WB, Hettich I, Ruzicka D, Holper K, Schricker C, Bleiziffer S, Lange R (2008) Twenty-year experience with the St.-Jude medical biocor prosthesis in the aortic position. Ann Thorac Surg 86:1204–1211CrossRefPubMedGoogle Scholar
  67. 67.
    Yankah CA, Schubel J, Buz S, Siniawski H, Hetzer R (2005) Seventeen-year clinical results of 1037 Mitroflow pericardial heart valve prostheses in the aortic position. J Heart Valve Dis 14:172–180PubMedGoogle Scholar
  68. 68.
    Aupart MR, Mirza A, Muerisse YA, Sirinelli AL, Neville PH, Marchand MA (2006) Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients J Heart Valve Dis 15:768–776PubMedGoogle Scholar
  69. 69.
    Puvimanasinghe JP, Takkenberg JJ, Edwards MB, Eijkemans MJ, Steyerberg EW, Van Herwerden LA, Taylor KM, Grunkemeier GL, Habbema JD, Bogers AJ (2004) Comparison of outcomes after aortic valve replacement with a mechanical valve or a bioprosthesis using microsimulation. Heart 90:1172–1178CrossRefPubMedGoogle Scholar
  70. 70.
    Takkenberg JJ, Eijkemans MJ, van Herwerden LA, Steyerberg EW, Lane MM, Elkins RC, Habbema JD and Bogers AJ (2003) Prognosis after aortic root replacement with cryopreserved allografts in adults. Ann Thorac Surg 75;5:1482–1489CrossRefPubMedGoogle Scholar
  71. 71.
    Takkenberg JJ, Klieverik LM, Schoof PH, van Suylen RJ, van Herwerden LA, Zondervan PE, Roos-Hesselink JW, Eijkemans MJC, Yacoub MH and Bogers AJ (2009) The Ross procedure: A systematic review and meta-analysis. Circulation 119(2):222–228CrossRefPubMedGoogle Scholar
  72. 72.
    Takkenberg JJ, Puvimanasinghe JP, Grunkemeier GL (2003) Simulation models to predict outcome after aortic valve replacement. Ann Thorac Surg 75:1372–1376CrossRefPubMedGoogle Scholar
  73. 73.
    Jamieson WR, Burr LH, Miyagishima RT, Janusz MT, Fradet GJ, Ling H, Lichtenstein SV (2003) Re-operation for bioprosthetic aortic structural failure — risk assessment. Eur J Cardiothorac Surg 24:873–887CrossRefPubMedGoogle Scholar
  74. 74.
    Musci M, Siniawski H, Pasic M, Weng Y, Loforte A, Kosky S, Yankah C, Hetzer R (2008) Surgical therapy in patients with active infective endocarditis: seven-year single centre experience in a subgroup of 255 patients with the Shelhigh stentless bioprosthesis Eur J Cardiothorac Surg 34:410–417CrossRefPubMedGoogle Scholar
  75. 75.
    Morgan JA, Park Y, Oz MC, Naka Y (2003) Device-related infections while on left ventricular assist device support do not adversely impact bridging to transplant or posttransplant survival ASAIO J 49(6):748–750CrossRefPubMedGoogle Scholar
  76. 76.
    Mestres CA, Ginel A, Cartana R, Pomar JL (1993) Cryopreserved homografts in aortic and mitral prosthetic endocarditis: expanding the use of biological tissues in complex cardiac infections. J Heart Valve Dis 2:679–683PubMedGoogle Scholar
  77. 77.
    Bechtel JF, Gellissen J, Erasmi AW, Petersen M, Hiob A, Stierle U, Sievers HH (2005) Mid-term findings on echocardiography and computed tomography after RVOT reconstruction. Comparison of decellulaized (SynerGraft) and conventional allografts. Eur J Cardiothorac Surg 27(3):410–415, discussion 415CrossRefPubMedGoogle Scholar
  78. 78.
    Dohmen PM, Konertz W (2008) Decellularized biologic tissue. Ann Thorac Surg 85(6):2163–2164CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Charles A. Yankah
    • 1
  • M. Pasic
  • Henryk Siniawski
    • 1
  • Y. Weng
  • Roland Hetzer
    • 1
  1. 1.Deutsches Herzzentrum Berlin & Charité Medical University BerlinBerlinGermany

Personalised recommendations